LatchBio
San Francisco
About LatchBio
LatchBio develops a data infrastructure intended to build and disseminate the open-source infrastructure of the biocomputing revolution. Founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, the company creates open-source machine learning and cloud infrastructure for the next generation of therapeutic discovery, thereby enabling biotech companies to find therapies faster and save on engineering.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $33.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2022)
- Website: latch.bio
- Phone: 510-666-5434
Industries & Categories
Artificial Intelligence (AI), Bioinformatics, Biopharma, Biotechnology, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/latchbio-75665 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.